Abbott Laboratories (Pakistan) Ltd operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Abbott Laboratories (Pakistan) Ltd with three other
companies in this sector in PAKISTAN :
Searle Co Ltd
sales of 20.47 billion Pakistan Rupees [US$130.02 million]
GlaxoSmithKline Pakistan Limited
(35.09 billion Pakistan Rupees [US$222.82 million]
Glaxosmithkline Consumer Healthcare Pakistan Ltd
(19.85 billion Pakistan Rupees [US$126.02 million]
of which 100%
was Consumer HealthCare).
During the first
quarter of 2021, sales at Abbott Laboratories (Pakistan) Ltd totalled
9.89 billion Pakistan Rupees .
an increase of 22.7%
from the 8.06 billion Pakistan Rupees in sales at the company during the first quarter of 2020.
There appears to be at least some degree of seasonality in the sales at Abbott Laboratories (Pakistan) Ltd: during 7 of the previous 8
years, sales were highest during the fourth quarter.
The exception to this was during 2019, when the
second quarter was the best quarter, accounting for
27% of sales (during that same year, the
fourth quarter accounted for 26% of sales).
During the year ended December of 2020, sales at
Abbott Laboratories (Pakistan) Ltd were 35.28 billion Pakistan Rupees (US$224.05 million).
increase of 17.0%
versus 2019, when the company's sales were 30.16 billion Pakistan Rupees .
This was the fifth consecutive year of sales increases at Abbott Laboratories (Pakistan) Ltd
(and since 2015, sales have increased a total of 67%).
Sales of Nutritional saw an increase
that was more than double the company's growth rate: sales were up
37.5% in 2020, from
6.20 billion Pakistan Rupees to 8.53 billion Pakistan Rupees .
Not all segments of Abbott Laboratories (Pakistan) Ltd experienced an increase in sales in 2020:
sales of Other fell 73.6% to 727.25 million Pakistan Rupees .